• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

JPM2024: Cancer Biotech Executives Look Ahead to the Coming Year

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 11, 2024 at 09:22: PM
via Biotechs in the cancer space are preparing for readouts and other developments for the year. BioSpace sat down with several executives in the cancer space to talk about their coming year and the critical role of JPM.

article source
 




Top Bottom
Back
Quote